Top Markets
Coin of the day
BioNexus Gene Lab Corp. BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp.

BGLC
Clasificación en acciones #35594
BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala... BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
Precio por acción
$1.50
Última sincronización: 2026-09-21
Capitalización bursátil
$3.63M
Cambio (1 día)
-4.46%
Cambio (1 año)
-72.68%
País
MY
Comercio BioNexus Gene Lab Corp. (BGLC)

Categoría

EPS de BioNexus Gene Lab Corp. (BGLC)
EPS a fecha de June 2026 TTM: $-1.26
Según los últimos informes financieros y el precio de las acciones de BioNexus Gene Lab Corp., el EPS actual de la empresa (TTM) es $-1.26. Al final del año 2023, la empresa tenía un EPS de $-1.53 un aumento con respecto a al EPS de 2022, que fue de $-0.25.
Historial de EPS de BioNexus Gene Lab Corp. desde 2016 hasta 2026
EPS al final de cada año
Año EPS Cambiar
2026 (TTM) $-1.26 40.00%
2024 $-0.90 -41.18%
2023 $-1.53 512.00%
2022 $-0.25 -147.17%
2021 $0.53 -58.59%
2020 $1.28 -3,842.69%
2019 $-0.03 -812.50%
2018 0.00 -124.12%
2017 $-0.02 19,800.00%
2016 0.00 0.00%
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
$39.24 -3,214.29%
US
$1.18 -193.65%
US
- -
US
$14.65 -1,262.70%
US
- -
US